These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33469248)

  • 41. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm.
    Oprica C; Emtestam L; Lapins J; Borglund E; Nyberg F; Stenlund K; Lundeberg L; Sillerström E; Nord CE
    Anaerobe; 2004 Jun; 10(3):155-64. PubMed ID: 16701513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics.
    Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA
    JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of antimicrobial-resistant Cutibacterium isolates and development of multiplex PCR method for Cutibacterium species identification.
    Koizumi J; Nakase K; Hayashi N; Nasu Y; Hirai Y; Nakaminami H
    J Infect Chemother; 2023 Feb; 29(2):198-204. PubMed ID: 36336238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris.
    Delost GR; Delost ME; Armile J; Lloyd J
    J Am Acad Dermatol; 2016 Apr; 74(4):673-8. PubMed ID: 26777099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic antibiotic therapy of acne vulgaris.
    Ochsendorf F
    J Dtsch Dermatol Ges; 2006 Oct; 4(10):828-41. PubMed ID: 17010172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Propionibacterium acnes resistance to antibiotics in acne patients.
    Leyden JJ; McGinley KJ; Cavalieri S; Webster GF; Mills OH; Kligman AM
    J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbiomes in Acne Vulgaris and Their Susceptibility to Antibiotics in Indonesia: A Systematic Review and Meta-Analysis.
    Legiawati L; Halim PA; Fitriani M; Hikmahrachim HG; Lim HW
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G; Critchley I; Lin LY; Alvandi N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls.
    Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M
    Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
    Fluhr JW; Gloor M; Dietz P; Höffler U
    Zentralbl Bakteriol; 1999 Feb; 289(1):53-61. PubMed ID: 10096167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-antibiotic Isotretinoin Treatment Differentially Controls
    Ryan-Kewley AE; Williams DR; Hepburn N; Dixon RA
    Front Microbiol; 2017; 8():1381. PubMed ID: 28790988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.
    Swallow MA; Fan R; Cohen JM; Bunick CG
    Antibiotics (Basel); 2022 Jul; 11(8):. PubMed ID: 36009899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial Susceptibility of
    Solís MB; Zurita J; Velasco N; Dressendorfer LM
    Skinmed; 2018; 16(3):159-165. PubMed ID: 29989535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium sulphate mixed with antibiotics does not decrease efficacy against
    Couture A; Lavergne V; Sandman E; Leduc JM; Benoit B; Leduc S; Rouleau DM
    J Orthop; 2020; 19():138-142. PubMed ID: 32025121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic-resistant acne: getting under the skin.
    Sinha M; Sadhasivam S; Bhattacharyya A; Jain S; Ghosh S; Arndt KA; Dover JS; Sengupta S
    Semin Cutan Med Surg; 2016 Jun; 35(2):62-7. PubMed ID: 27416310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Systemic antibiotic therapy of acne vulgaris].
    Ochsendorf F
    J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S31-46. PubMed ID: 20482690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.